NRX Pharmaceuticals, Inc.

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: NRX Pharmaceuticals, Inc. was delisted from its exchange (May 22, 2026)

Every material event, newest first. History is never overwritten.

NRX Pharmaceuticals, Inc. was delisted from its exchange
May 22, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001719406 NRX Pharmaceuticals, Inc. 001-38302 1201 Orange Street Suite 600 Wilmington DE DELAWARE 19801 (484) 254-6134 Warrant 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-05-22”
NRX Pharmaceuticals, Inc. received a delisting notice from its exchange
Jan 12, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2026, the Company received a letter from the Listing Qualifications Staff of the Nasdaq notifying the Company that it is no longer in compliance with Nasdaq Listing Rules, which requires the Company to hold an annual meeting of shareholders within twelve months of the end of the Company s fiscal year end (the Nasdaq Letter ). The Nasdaq Letter states that the Company has 45 calendar days to submit a plan to regain compliance. If Nasdaq accepts the Company s plan, Nasdaq…”

Every material source used to build this profile.

SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001719406 NRX Pharmaceuticals, Inc. 001-38302 1201 Orange Street Suite 600 Wilmington DE DELAWARE 19801 (484) 254-6134 Warrant 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-05-22
View source record
SEC Company Submissions (TIER 1 · UNVERIFIED)
NRX Pharmaceuticals, Inc. — Pharmaceutical Preparations (SIC 2834) — WILMINGTON, DE
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2026, the Company received a letter from the Listing Qualifications Staff of the Nasdaq notifying the Company that it is no longer in compliance with Nasdaq Listing Rules, which requires the Company to hold an annual meeting of shareholders within twelve months of the end of the Company s fiscal year end (the Nasdaq Letter ). The Nasdaq Letter states that the Company has 45 calendar days to submit a plan to regain compliance. If Nasdaq accepts the Company s plan, Nasdaq…
View source record

Every derived status, with the rule that produced it.

DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:31 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:44 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:59 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.